Private Hospitals Carrying Out Illegal Gender Selection
By Saudi Gazette,
Saudi Gazette
| 12. 18. 2014
DAMMAM — Private hospitals are carrying out pre-conception gender selection operations and reporting them as IV fertilization or artificial fertilization in response to a growing number of patients’ requests, Al-Hayat daily reported.
Pre-conception gender selection operations are prohibited by the Ministry of Health although there are no religious prohibitions.
Sheikh Khalid Abdulah Al-Muslih said in his study on such procedures that scholars are split on the issue.
There is no religious text forbidding gender selection before conception, said Sheikh Al-Muslih.
Eastern Province Health Affairs spokesman Khalid Al-Osaimi said such operations are forbidden and would never happen in public hospitals. Sociologists believed parents who want such operations are looking to have boys, especially if there are none in their families.
Sociologist Saleh Al-Nimer said pre-conception gender selection operations have led to decreased rates of divorce in the Kingdom’s patriarchal society.
Many wives fear their husbands will replace them if they do not conceive a boy, said Al-Nimer.
The Eastern Province’s supervisor of private hospitals’ fertility units Dr. Essam Al-Hameed said these operations are not carried out in public hospitals, only private...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...